Eli Lilly Takes Legal Action Against Fake Mounjaro Weight Loss Sales in the US

Eli Lilly has filed lawsuits against 10 medical spas, wellness centers, and compounding pharmacies in the US for selling products claiming to contain tirzepatide, the active ingredient in its diabetes drug Mounjaro. The company is seeking injunctions to prevent the sale of these unregulated versions of Mounjaro and is also requesting unspecified damages. Eli Lilly accuses the defendants of violating consumer protection and competition laws by selling unauthorized versions of the drug. The lawsuits come after rival company Novo Nordisk sued several medical spas and compounding pharmacies for selling products claiming to contain semaglutide, the main ingredient in its obesity treatment Wegovy.